62 Days
Source:
عربية – DW
عربية – DW
Ready to play
Ready to play
A long-term study showed that 66% of patients with high-grade gliomas are still alive after eight years, with 42% of them experiencing no tumor recurrence. The new development of a vaccine targeting a genetic mutation in brain tumors aims to activate the immune system and combat cancer cells, representing a promising step in efforts to prevent tumor relapse after treatment. However, further extensive research is still needed to ensure its effectiveness before it can be approved as a potential therapy.
Notice: This Is an AI-Generated Summary
Comments (0)